A selective agonist of human TLR7
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Gardiquimod

Item No. 18877

Technical Information
Formal Name
4-amino-2-[(ethylamino)methyl]-α,α-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol
CAS Number
1020412-43-4
Molecular Formula
C17H23N5O
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 20 mg/mlDMSO: 20 mg/mlEthanol: 12 mg/mlPBS (pH 7.2): 0.2 mg/ml
λmax
249, 328 nm
SMILES
NC1=NC2=C(C3=C1N=C(CNCC)N3CC(C)(O)C)C=CC=C2
InChi Code
InChI=1S/C17H23N5O/c1-4-19-9-13-21-14-15(22(13)10-17(2,3)23)11-7-5-6-8-12(11)20-16(14)18/h5-8,19,23H,4,9-10H2,1-3H3,(H2,18,20)
InChi Key
FHJATBIERQTCTN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8.1 At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells.2 Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1.3,4 It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhu, J., Lai, K., Bronile, R., et alPorcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. Mol. Immunol. 45(11), 3238-3243 (2008).

    2. Forward, N.A., Furlong, S.J., Yang, Y., et alSignaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. J. Leukoc. Biol. 87(1), 117-125 (2010).

    3. Velasquez, L.S., Hjelm, B.E., Arntzen, C.J., et alAn intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin. Vaccine Immunol. 17(12), 1850-1858 (2010).

    4. Buitendijk, M., Eszterhas, S.K., and Howell, A.L. Gardiquimod: A toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells. AIDS Res. Hum. Restroviruses 29(6), 907-918 (2013).

    5. Zou, B.B., Wang, F., Li, L., et alActivation of Toll-like receptor 7 inhibits the proliferation and migration, and induces the apoptosis of pancreatic cancer cells. Mol. Med. Rep. 12(4), 6079-6085 (2015).